Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Cisplatin and Magnesium

supplement:

Magnesium

Research Papers that Mention the Interaction

The concentration of magnesium in serum has been shown to fall to potentially dangerously low levels after several courses of treatment with cis-diamminedichloroplatinum II (cis-platin).
British Journal of Cancer  •  1986  |  View Paper
While magnesium status did not interfere with tumor killing by cisplatin, it significantly affected renal function following cisplatin.
American journal of physiology. Renal physiology  •  2015  |  View Paper
A number of drugs have been shown to alter magnesium handling ; these include antibiotics such as gentamicin, antineoplastic agents such as cisplatin and immunological suppressive drugs such as cyclosporin.
Magnesium  •  1986  |  View Paper
In addition, the administration of magnesium and mannitol may assist in maintaining renal function and reducing nephrotoxicity in adults receiving cisplatin.
Clinical journal of oncology nursing  •  2018  |  View Paper
Urine neutrophil gelatinase‐associated lipocalin to urine creatinine ratio (NGAL/Cr) and urinary magnesium and potassium wasting increased significantly after cisplatin infusion in both groups.
Phytotherapy research : PTR  •  2015  |  View Paper
Amifostine, calcium and magnesium , glutathione, and vitamin E showed modest but promising (borderline statistically significant) results favouring their ability to reduce the neurotoxicity of cisplatin and related chemotherapies, as measured using secondary, non-quantitative and subjective measures such as the NCI-CTC neuropathy grading scale.
The Cochrane database of systematic reviews  •  2014  |  View Paper
Moreover, it was found a sub-group of MGs including ASS1, JUNB, PTGS2, EEF2, SULF1, TOP2A, AURKA, BIRC5, CAV1, IFITM1, PCNA, and PKM2 that could explain, at least in part, the mechanisms of resistance to cisplatin , one first-line chemotherapeutic drug used for the disease.
Mutation research  •  2012  |  View Paper
Within an oncology setting, certain chemotherapy drugs, such as cisplatin , may lead to magnesium loss causing nephropathy.
Supportive Care in Cancer  •  2012  |  View Paper
CPL has been shown to result in renal magnesium loss and reduced glomerular filtration rate, and its toxicity clearly differs from IFO-mediated tubulopathy.
European Journal of Clinical Pharmacology  •  2005  |  View Paper
We conclude that cisplatin alters renal tubular handling of magnesium , resulting in significant prolonged dose-related hypomagnesemia.
American journal of kidney diseases : the official journal of the National Kidney Foundation  •  1986  |  View Paper
Show More